Recently, Medical Properties Trust Inc (Symbol: MPW) saw its shares climb above the analyst-set average 12-month target price of $4.44, now trading at $4.57 per share. When a stock hits an analyst’s target price, the analyst typically has two options: either downgrade the stock due to valuation concerns or adjust their target to a higher level. The decision often depends on recent developments in the company’s business that could be influencing the stock’s upward movement.
There are eight analysts contributing to the average target for Medical Properties Trust Inc as tracked by Zacks. However, this average encompasses a range of forecasts. For instance, while one analyst predicts a target of $3.00, another sees a potential high of $6.50. This results in a standard deviation of $1.05 among estimates.
The average price target serves to aggregate diverse opinions, allowing for a “wisdom of crowds” effect. With MPW now surpassing the $4.44 target, investors are prompted to evaluate whether this price is a stepping stone to even greater heights or if it signifies an overvaluation, suggesting it might be prudent to sell some shares. Below, find a table detailing the current perspectives of analysts covering Medical Properties Trust Inc:
| Recent MPW Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
| Strong buy ratings: | 0 | 0 | 0 | 0 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 7 | 7 | 7 | 7 |
| Sell ratings: | 1 | 1 | 1 | 1 |
| Strong sell ratings: | 3 | 3 | 3 | 3 |
| Average rating: | 3.5 | 3.5 | 3.5 | 3.5 |
The average rating in the table ranges from 1 (Strong Buy) to 5 (Strong Sell). Data for this analysis was supplied by Zacks Investment Research through Quandl.com. For further information, check out the latest Zacks research report on MPW — FREE.
The Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
QVMS Videos
Top Ten Hedge Funds Holding SUGP
SBXC YTD Return
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
